. This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

19 October 2021

Tekcapital Plc

("Tekcapital", the "Company" or the "Group")

Portfolio Company Update: Lucyd Ltd ("Lucyd")

 Filing of Draft Registration Statement for IPO of

Innovative Eyewear, Inc. in the United States

Tekcapital Plc (AIM: TEK, OTCQB: TEKCF) is pleased to announce that Innovative Eyewear Inc., a U.S. operating subsidiary of its portfolio company Lucyd Ltd, submitted a draft registration statement on a confidential basis with the U.S. Securities and Exchange Commission (the "SEC"), for a proposed initial public offering ("IPO") of shares of its common stock in the United States. Tekcapital currently owns 100% of the share capital of Lucyd Ltd and approximately 80% of the share capital of Innovative Eyewear, Inc.

The number of shares of common stock to be sold and the price range for the proposed IPO have not yet been determined. Innovative Eyewear intends to commence the IPO following completion of the SEC review process, subject to market and other conditions.

At this stage there can be no certainty on the IPO proceeding nor the terms or timing of the IPO. Further announcements will be made, as required, in due course.

This announcement is being made pursuant to and in accordance with Rule 135 under the Securities Act of 1933, as amended (the "Securities Act"). As required by Rule 135, this press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act.

For further information, please contact: